Physician profile
Ruosu An
NPI 1447541545
$17,580.06
in general payments reported to CMS, 2019-2025
24 companies · $4,830 in 2025
The $4,830 reported for 2025 was more than what 84% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,986 · 2020: $995 · 2021: $1,400 · 2022: $816 · 2023: $3,802 · 2024: $3,751 · 2025: $4,830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $12K · Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $12,000.00 |
| Food and Beverage | $382.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $12,032.90 | 2021-2025 | Venacure 1470 Pro |
| Silk Road Medical, INC. | $1,133.85 | 2019-2021 | |
| Cardiovascular Systems INC. | $924.28 | 2019-2022 | |
| Endologix LLC | $663.05 | 2019-2022 | |
| Biotronik INC. | $646.98 | 2020-2022 | |
| Bard Peripheral Vascular, INC. | $542.19 | 2020-2025 | Venclose Maven Catheter |
| W. L. Gore & Associates, INC. | $497.92 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $197.86 | 2019-2022 | |
| Smith+Nephew, INC. | $148.52 | 2019-2023 | Oasis, Grafix Pl |
| Becton, Dickinson and Company | $135.96 | 2024 | Venclose Maven Catheter |
| Pfizer INC. | $132.45 | 2019-2022 | |
| Bolton Medical INC | $89.05 | 2021-2022 | |
| Abbott Laboratories | $88.89 | 2020-2024 | Jeti Peripheral Catheter, Jeti All In One Non-Sterile Kit |
| Teleflex LLC | $52.03 | 2020-2021 | |
| Boston Scientific Corporation | $51.85 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $41.95 | 2022 | |
| Kci USA, INC. | $38.57 | 2019-2020 | |
| Normatec Industries, LP | $38.26 | 2019-2020 | |
| Shockwave Medical, INC | $27.39 | 2019 | |
| Ekos Corporation | $23.43 | 2019 | |
| Philips North America LLC | $19.98 | 2020 | |
| Biocompatibles, INC. | $19.97 | 2019 | |
| Stryker Corporation | $18.10 | 2021 | |
| Aroa Biosurgery Incorporated | $14.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruosu An listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.